Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* patients with liver function disorder. * vco hypersensitivity. * patients with severe pneumonia and/or acute respiratory distress syndrome (ards). * pregnant patients. * patients with malignant comorbidity. * critical or unconscious patients. * patients using other immunomodulators similar to vco within less than three days before vco administration.	* patients with liver function disorder. * vco hypersensitivity. * patients with severe pneumonia and/or acute respiratory distress syndrome (ards). * pregnant patients. * patients with malignant comorbidity. * critical or unconscious patients. * patients using other immunomodulators similar to vco within less than three days before vco administration.
Oct. 26, 2020, 11:31 p.m.	usa	- patients with liver function disorder. - vco hypersensitivity. - patients with severe pneumonia and/or acute respiratory distress syndrome (ards). - pregnant patients. - patients with malignant comorbidity. - critical or unconscious patients. - patients using other immunomodulators similar to vco within less than three days before vco administration.	- patients with liver function disorder. - vco hypersensitivity. - patients with severe pneumonia and/or acute respiratory distress syndrome (ards). - pregnant patients. - patients with malignant comorbidity. - critical or unconscious patients. - patients using other immunomodulators similar to vco within less than three days before vco administration.